Pioneering Efficacious RNA Medicines Across Asia for Patients Faster
Uniquely positioned as the most comprehensive biopharma forum, the RNA-Based Therapeutic & Vaccine Summit Asia unites RNA leaders, innovative start-ups and solution providers to showcase new trends in RNA design leveraging artificial intelligence, novel lipid nanoparticle technologies, CMC and analytical strategic and decentralized manufacturing, covering the end-to-end of RNA drug development whilst forging new collaborative networking opportunities.
This conference offered the opportunity to engage with the leading companies including Pfizer, Abogen Bio, Starna Therapeutics and more, making the biggest leaps in RNA therapeutic and vaccine research towards commercial markets, tailored to your needs and gaining first-hand insights to advance your RNA centric pipelines.
2025 Sessions:
Yu Pang, Senior Scientist, Pfizer
Development of Alternative Analytical Method for mRNA Product Characterization
Yeong-Chan Ahn, Business Development Director, SML Biopharm
Advancing Antibody Therapeutics Through In Vivo mRNA-LNP Delivery
Kee-Jong Hong, Professor, Gachon University School of Medicine & Director General, Korea mRNA Vaccine Initiative (KmVAC)
Establishing a Two-Track Strategy & Platform Technology Required for Next Pandemic Preparedness
Yasumasa Ota, mRNA technology Leader, Meiji Seika Pharma
Development & CMC Perspectives on the Next-Generation sa-mRNA Vaccine, KOSTAIVE
Key Takeaways:
Achieve scalable process development, CMC and decentralized GMP-grade manufacturing for your RNA development and capabilities for pandemic preparedness and commercial readiness
Unlock innovative non-viral delivery strategies for RNA payloads from LNPs to polymeric
particles with stable formulations, sitespecific
targeting and reduced immunogenicity
Develop a robust CMC and analytical process to effectively assess, characterize and release your products into market with regulatory compliance
Advance your progress toward the clinic with fresh data and experience from leading Asian RNA developers focusing on in vivo CAR-T, personalized cancer medicine and protein replacement therapies
Harness novel artificial intelligence and machine
learning capabilities to accelerate your discovery efforts from antigen target identification, RNA sequence design and ionizable lipid screening
Explore the 2025 Full Event Guide
- 80+ RNA Experts
- 30+ Speakers from Biopharma & Academia
- 12+ APAC Countries Attending
- 8+ Hours of Networking Time
- 2 Interactive & Deep-Diving Workshops
- 1 Ultimate Summit for RNA Progress
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.